Management of alopecia areata: Updates and algorithmic approach
- 21 June 2017
- journal article
- review article
- Published by Wiley in The Journal of Dermatology
- Vol. 44 (11) , 1199-1211
Abstract
Alopecia areata is a chronic, recurrent and non‐scarring alopecia. The prognoses of patients are very diverse. The larger the area of hair loss, the poorer the treatment response and greater the probability of chronic disease progression. Numerous treatments have been introduced, but curative treatments have yet to be established. The long‐term efficacy of the current treatments is minimal, and the therapeutic response varies widely. Recent clinical trials have attempted to apply therapeutic metrics, such as the Severity of Alopecia Tool, and many have been designed as randomized controlled studies, enabling a more precise evaluation of existing treatments. There have been updates in practice, efficacy or indications of therapeutics that have been previously used. Moreover, the use of novel treatments such as biologics has recently been introduced. Commonly, the most important factor in determining the treatment modality for alopecia areata has been the extent of hair loss. However, if the disease activity is high and likely to progress, combination therapy with adjuvant modalities will be more desirable. This review will discuss the therapeutic effects of existing and newly‐introduced treatments based on their quantity, quality of evidence and expected complications. In addition, an algorithmic approach to management of alopecia areata is proposed according to clinical subtype, severity, onset and activity of the disease.Keywords
This publication has 120 references indexed in Scilit:
- Hypnosis in refractory alopecia areata significantly improves depression, anxiety, and life quality but not hair regrowthJournal of the American Academy of Dermatology, 2010
- Is there a role for sulfasalazine in the treatment of alopecia areata?Journal of the American Academy of Dermatology, 2007
- Hypnotherapeutic management of alopecia areataJournal of the American Academy of Dermatology, 2006
- Etanercept does not effectively treat moderate to severe alopecia areata: An open-label studyJournal of the American Academy of Dermatology, 2005
- Placebo-controlled oral pulse prednisolone therapy in alopecia areataJournal of the American Academy of Dermatology, 2005
- Topical tacrolimus in alopecia areataJournal of the American Academy of Dermatology, 2005
- Alopecia areata investigational assessment guidelines–Part IIJournal of the American Academy of Dermatology, 2004
- Topical 5-fluorouracil is ineffective in the treatment of extensive alopecia areataJournal of the American Academy of Dermatology, 2004
- Systemic cyclosporine and low-dose prednisone in the treatment of chronic severe alopecia areata: A clinical and immunopathologic evaluationJournal of the American Academy of Dermatology, 1997
- Oral cyclosporine for the treatment of alopecia areataJournal of the American Academy of Dermatology, 1990